Health Status and COVID-19 Epidemiology in an Inland Region of Portugal: A Retrospective Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 30 05 2024
revised: 24 07 2024
accepted: 31 07 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Multiple factors, from socioeconomic development to genetic background, can affect the regional impact of some diseases, and this has also been seen during the COVID-19 pandemic. The objective of this retrospective study was to characterize a population in the interior of Portugal regarding health status and COVID-19 epidemiology. Between October 2021 and January 2023, 1553 subjects residing in Beira Baixa, Portugal, were included. Using a self-report approach, demographic and clinical data were obtained. Blood group, blood pressure, peripheral oxygen saturation and anti-spike protein immunoglobulin concentration were also analyzed. Statistical analysis was performed using IBM SPSS Statistics. The average age of the participants was 48.95 (±14.43) years, with 64% being male and 36% being female. The most prevalent comorbidities were hypertension (19.2%), dyslipidemia (12.6%) and diabetes mellitus (6.6%). Half of the population was overweight, and more than half of the subjects had no history of tobacco consumption. Among the participants, 33% were infected with SARS-CoV-2: 70.1% had mild disease, 14.1% moderate disease and 1.4% severe disease. There was a very significant adherence to vaccination (97%). Previously infected or vaccinated people had higher anti-spike protein immunoglobulin values; this value depended on the vaccine administered (

Identifiants

pubmed: 39200643
pii: ijerph21081033
doi: 10.3390/ijerph21081033
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundação para a Ciência e Tecnologia
ID : COVID-19 (AAC 02/SAICT/2020

Auteurs

Jorge Lindo (J)

FMUC-Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.
CNC-UC-Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal.
Dermatology Department, Coimbra's Hospital and University Center, Unidade Local de Saúde de Coimbra, 3004-561 Coimbra, Portugal.

Patrícia Coelho (P)

Sport Physical Activity and Health Research & Innovation Center (Sprint), Polytechnic Institute of Castelo Branco, 6000-084 Castelo Branco, Portugal.

Catarina Gavinhos (C)

IPCB/ESALD-Instituto Politécnico de Castelo Branco, Escola Superior Agrária, UID-QRural, 6000-084 Castelo Branco, Portugal.

Manuel Martins (M)

IPCB/ESALD-Instituto Politécnico de Castelo Branco, Escola Superior Agrária, UID-QRural, 6000-084 Castelo Branco, Portugal.

Joana Liberal (J)

IPC/ESTSC-Instituto Politécnico de Coimbra, Escola Superior Tecnologia da Saúde de Coimbra, 3046-854 Coimbra, Portugal.

António Jorge Ferreira (AJ)

FMUC-Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.
CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal.

Teresa Gonçalves (T)

FMUC-Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.
CNC-UC-Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal.

Francisco Rodrigues (F)

Sport Physical Activity and Health Research & Innovation Center (Sprint), Polytechnic Institute of Castelo Branco, 6000-084 Castelo Branco, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH